Formal pathology review |
100.0% |
Complete colonic evaluation |
100.0% |
Tumor location documentation |
93.7% |
Documentation of sexual function and continence |
0.0% |
Tumor staging (ERUS or MRI) |
96.3% |
Metastatic staging evaluation |
100.0% |
Preoperative CEA Measurement |
93.8% |
Documentation of neoadjuvant therapy consideration |
100.0% |
Any post-neoadjuvant restaging performed |
69.3% |
By physical exam only |
31.4% |
By repeat imaging |
37.1% |
Documentation of multi-disciplinary discussion of therapy (Tumor Board) |
16.8% |
Preoperative stoma siting |
94.3% |
|
INTRA-OPERATIVE |
|
|
|
Exploration for extra-pelvic disease documented |
89.4% |
Total mesorectal excision performed |
98.8% |
Distal resection gross margin documented |
92.5% |
En bloc resection of involved organs |
100.0% |
Documentation of pelvic nerve integrity |
8.7% |
Documentation of resection status |
88.8% |
Rationale for intestinal continuity |
91.9% |
Documentation of anastomotic type (handsewn vs stapled) |
100.0% |
Rationale for anastomotic approach (pouch vs end-to-side) |
80.0% |
Documentation of anastomotic location |
92.3% |
Documentation of leak test |
52.9% |
Documentation of diversion consideration |
96.0% |
|
POSTOPERATIVE |
|
|
|
Stoma care teaching provided |
100.0% |
Postoperative medical oncology referral for Stage II or III cancers |
100.0% |
Documentation of radial and distal margin status |
57.5% |